Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.
about
The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individualsEpidemiology and pathogenesis of scleroderma.Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement.Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.Autoimmune mechanisms of scleroderma and a role of oxidative stress.Deciphering the genetic background of systemic sclerosis.T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
P2860
Q33877672-0ABF86D9-F5FC-421D-AB66-CFD3FF3E678DQ34540287-0C62B0E9-1D5A-4237-82A2-6F736C25EA7CQ35064351-1E3565C3-7D6A-4067-8EFE-E37FBC1707E4Q35609399-D3684A92-CD9E-4F9E-A74C-B01CEC6922B7Q35805025-C8C552E6-8726-4AF0-B378-6057F4EC2481Q37903252-97FB29B8-BECF-4062-AF8A-514DAF60CC16Q37905783-94C6D253-B577-4866-9062-A50F372676F1Q38601631-357D5586-EF67-443D-8275-1F1906915674
P2860
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.
@en
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.
@nl
type
label
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.
@en
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.
@nl
prefLabel
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.
@en
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.
@nl
P2093
P356
P1476
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis.
@en
P2093
P2888
P304
P356
10.1007/S004030050288
P577
1998-04-01T00:00:00Z